Researchers engineered a stable, prefusion Lassa virus GPC trimer, which, when used as an immunogen in animal models, elicited robust neutralizing antibody responses. https://www.nature.com/articles/s41541-025-01090-4 #virology #vaccine #LassaVirus #VaccineDevelopment #Immunology #EmergingViruses #Glycoprotein